Sulesomab
From Wikipedia, the free encyclopedia
|
Sulesomab?
|
|
| Therapeutic monoclonal antibody | |
| Source | Mouse |
| Target | ? |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | ? |
| Chemical data | |
| Formula | ? |
| Mol. mass | ? |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Sulesomab is a mouse monoclonal antibody, marketed under the brand name, LeukoScan which is used to treat inflammatory lesions. It contains a radioisotope, technetium (99m Tc) when it is added.
|
||||||||||||||||||||||||||

